F019-3075 Screening compound: 2-methyl-N~3~,4-bis(4-methylphenyl)-1,4-dihydropyrimido[1,2-a][1,3]benzimidazole-3-carboxamide

F019-3075 Screening compound: 2-methyl-N~3~,4-bis(4-methylphenyl)-1,4-dihydropyrimido[1,2-a][1,3]benzimidazole-3-carboxamide
F019-3075 Screening compound: 2-methyl-N~3~,4-bis(4-methylphenyl)-1,4-dihydropyrimido[1,2-a][1,3]benzimidazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F019-3075
2-methyl-N~3~,4-bis(4-methylphenyl)-1,4-dihydropyrimido[1,2-a][1,3]benzimidazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F019-3075

Molecular Formula

C26H24N4O (C26 H24 N4 O)

Compound Name

2-methyl-N~3~,4-bis(4-methylphenyl)-1,4-dihydropyrimido[1,2-a][1,3]benzimidazole-3-carboxamide

IUPAC name

11-methyl-N13-bis(4-methylphenyl)-1810-triazatricyclo[7.4.0.0^{27}]trideca-246811-pentaene-12-carboxamide

SMILES

Cc1ccc(C(C(C(Nc2ccc(C)cc2)=O)=C(C)N2)n3c2nc2c3cccc2)cc1

InChI

InChI=1S/C26H24N4O/c1-16-8-12-19(13-9-16)24-23(25(31)28-20-14-10-17(2)11-15-20)18(3)27-26-29-21-6-4-5-7-22(21)30(24)26/h4-15,24H,1-3H3,(H,27,29)(H,28,31)/t24-/m0/s1

InChI Key

KNKWVRFITFPPOT-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD08088709

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

408.5

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.778

Distribution Coefficient, logD

5.778

Water Solubility, LogSw

-5.65

Polar Surface Area

47.125

Acid Dissociation Constant (pKa)

11.31

Base Dissociation Constant (pKb)

-3.17

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

15.40

F019-3075 in Drug Discovery

Included in Screening Libraries

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with F019-3075 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F019-3075?
Check Price and Availability of F019-3075, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F019-3075 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F019-3075
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F019-3075
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F019-3075 available by request